Iodo-hexose compounds useful to treat cancer
AssigneeBoard of Regents, The University of Texas System
InventorsWaldemar Priebe, Slawomir Szymanski, Izabela Fokt, Charles Conrad, Timothy Madden
Life of this patent
Estimating the term…
Abstract
Methods of treating glioblastoma and pancreatic cancer are provided by the administration of a therapeutically effective amount of a iodo-hexose compound to a subject in need thereof. The subject disclosure includes methods of treating glioblastoma and pancreatic cancer comprising the administration of a therapeutically effective amount of a 2-deoxy-2-iodo-D-hexose compound including 2-deoxy-2-iodo-D-mannose, 2-deoxy-2-iodo-D-glucose, 2-deoxy-2-iodo-D-galactose, and/or 2-deoxy-2-iodo-D-talose to a subject in need thereof.
Claims7
A pharmaceutical composition comprising an iodo-hexose compound having the structural formula:
A composition comprising an iodo-hexose compound having the structural formula:
A method of treating glioblastoma or pancreatic cancer comprising the administration, to a patient in need thereof, of a therapeutically effective amount of at least one 2-deoxy-2-iodo-D hexose compound selected from the group consisting of 2-deoxy-2-iodo-D-mannose, 2-deoxy-2-iodo-D-talose, and 2-deoxy-2-iodo-D-galactose.
A method for achieving an effect in a patient comprising the administration of a therapeutically effective amount of at least one iodo-hexose compound selected from the group consisting of 2-deoxv-2-iodo-D-mannose, 2-deoxy-2-iodo-D-galactose, and 2-deoxy-2-iodo-D-talose, wherein the effect is reducing tumor growth resulting from at least one disease selected from the group consisting of pancreatic cancer and glioblastoma.
Dependencies are inferred from the claim text.